Rafael Holdings, Inc. RFL Product Revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s product revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s product revenue — revenue?
- Rafael Holdings, Inc. (RFL) reported product revenue — revenue of $89K in Q1 2026.
- What does product revenue — revenue mean?
- This metric represents the total gross income generated from the sale of pharmaceutical products or clinical therapies within the specific business segment. It reflects the company's ability to monetize its oncology-focused research and development pipeline through commercialized offerings. Tracking this figure helps investors assess the market adoption and revenue-generating potential of the company's therapeutic portfolio.